Blood borne infections and haemophilia: the worst of times

1. Bennett E, Dormandy KM, Churchill WG, et al. Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia. Br Med J 1967; 2: 88-91.10.1136/bmj.2.5544.88Search in Google Scholar

2. Levine PH, McVerry BA, Attock B, Dormandy KM. Health of the intensively treated hemophiliac, with special reference to abnormal liver chemistries and splenomegaly. Blood 1977; 50: 1-9.10.1182/blood.V50.1.1.1Search in Google Scholar

3. Kernoff PB, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985; 60: 469-79.10.1111/j.1365-2141.1985.tb07444.xSearch in Google Scholar

4. Lee CA, Kernoff PB, Peters DK. Cryoglobulinaemia in haemophilia. Br Med J (Clin Res Ed) 1985; 290: 1947-8.10.1136/bmj.290.6486.1947Search in Google Scholar

5. Lee CA, Kernoff PB, Karayiannis P, Thomas HC. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia. Br J Haematol 1989; 72: 235-8.10.1111/j.1365-2141.1989.tb07688.xSearch in Google Scholar

6. Lee CA, Phillips A, Elford J, Miller EJ, et al. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol 1989; 73: 228-34.10.1111/j.1365-2141.1989.tb00257.xSearch in Google Scholar

7. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337: 389-92.10.1016/0140-6736(91)91166-RSearch in Google Scholar

8. Phillips AN, Sabin CA, Elford J, et al. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ 1994; 309: 309-13.10.1136/bmj.309.6950.309Search in Google Scholar

9. Darby SC, Kan SW, Spooner RJ, et al. The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS 2004; 18: 525-33.10.1097/00002030-200402200-00020Search in Google Scholar

10. Anon. Post-transfusion hepatitis. Br Med J (Clin Res Ed) 1981; 283: 1-2.10.1136/bmj.283.6283.1Search in Google Scholar

11. Biggs R. Witnessing medical history: an interview with Dr Rosemary Biggs. Interview by Christine Lee and Charles Rizza. Haemophilia 1998; 4: 769-77.10.1046/j.1365-2516.1998.00199.xSearch in Google Scholar

12. Dudley NE, Kernoff PB, Gough MH. Surgery in children with congenital disorders of blood coagulation. J Pediatr Surg 1971; 6: 689-701.10.1016/0022-3468(71)90847-5Search in Google Scholar

13. Rizza CR. Historical annotation. Haemophilia 1995; 1: 210-2.10.1111/j.1365-2516.1995.tb00073.xSearch in Google Scholar

14. Yee TT, Griffioen A, Sabin CA, et al. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000; 47: 845-51.10.1136/gut.47.6.845Search in Google Scholar

15. Schwartz RS, Abildgaard CF, Aledort LM, et al. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med 1990; 323: 1800-5.10.1056/NEJM199012273232604Search in Google Scholar

16. Ludlam CA, Turner ML. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. Br J Haematol 2006; 132: 13-24.10.1111/j.1365-2141.2005.05796.xSearch in Google Scholar

17. Lee CA, Ironside JW, Bell JE, et al. Retrospective neuropathological review of prion disease in UK haemophilic patients. Thromb Haemost 1998; 80: 909-11.10.1055/s-0037-1615387Search in Google Scholar

18. Peden A, McCardle L, Head MW, et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296-304. doi: 10.1111/j.1365-2516.2009.02181.x.Search in Google Scholar